GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Little House Capital LLC

Little House Capital LLC grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.6% in the first quarter, HoldingsChannel reports. The fund owned 7,933 shares of the company’s stock after buying an additional 490 shares during the period. Little House Capital LLC’s holdings in GE HealthCare Technologies were worth $721,000 as of its most recent filing with the SEC.

Other institutional investors have also bought and sold shares of the company. Envestnet Portfolio Solutions Inc. acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter worth $256,000. LPL Financial LLC raised its holdings in GE HealthCare Technologies by 22.2% during the 3rd quarter. LPL Financial LLC now owns 173,597 shares of the company’s stock worth $11,812,000 after buying an additional 31,565 shares during the period. Tower Research Capital LLC TRC lifted its stake in GE HealthCare Technologies by 80.0% during the third quarter. Tower Research Capital LLC TRC now owns 25,491 shares of the company’s stock valued at $1,734,000 after buying an additional 11,331 shares in the last quarter. 683 Capital Management LLC increased its position in shares of GE HealthCare Technologies by 950.0% in the third quarter. 683 Capital Management LLC now owns 425,000 shares of the company’s stock worth $28,917,000 after acquiring an additional 475,000 shares in the last quarter. Finally, Logan Capital Management Inc. raised its holdings in shares of GE HealthCare Technologies by 68.7% during the third quarter. Logan Capital Management Inc. now owns 1,228 shares of the company’s stock valued at $84,000 after acquiring an additional 500 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, insider Frank R. Jimenez bought 1,315 shares of the firm’s stock in a transaction dated Wednesday, May 1st. The shares were acquired at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the transaction, the insider now owns 75,796 shares in the company, valued at $5,799,909.92. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, insider Frank R. Jimenez acquired 1,315 shares of the company’s stock in a transaction on Wednesday, May 1st. The stock was purchased at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the completion of the purchase, the insider now directly owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CTO Taha Kass-Hout sold 3,300 shares of GE HealthCare Technologies stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total value of $259,710.00. Following the transaction, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at $5,296,510. The disclosure for this sale can be found here. In the last quarter, insiders have sold 90,482 shares of company stock valued at $7,369,137. 0.27% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Mizuho cut their target price on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research note on Wednesday, May 1st. Bank of America lowered their target price on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Evercore ISI increased their price target on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Finally, Argus lifted their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.09.

GE HealthCare Technologies Stock Performance

Shares of GEHC traded down $1.40 during mid-day trading on Monday, hitting $76.52. The company’s stock had a trading volume of 1,983,308 shares, compared to its average volume of 3,186,520. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The stock’s 50-day moving average is $79.85 and its two-hundred day moving average is $81.85. The firm has a market capitalization of $34.93 billion, a PE ratio of 22.78, a price-to-earnings-growth ratio of 2.80 and a beta of 1.20. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.83 and a current ratio of 1.06.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.90. The company had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The business’s quarterly revenue was down 1.2% on a year-over-year basis. During the same period last year, the business posted $0.85 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be issued a $0.03 dividend. The ex-dividend date of this dividend is Friday, July 19th. This represents a $0.12 annualized dividend and a yield of 0.16%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.